Literature DB >> 6722773

New storage procedure for human tumor biopsies prior to estrogen receptor measurement.

D Crawford, S Cowan, S Hyder, M McMenamin, D Smith, R Leake.   

Abstract

Breast tumor biopsies required for steroid receptor determination are normally frozen in liquid nitrogen and stored until assay. However, some limitations of this type of storage exist. To try to both eliminate the need for liquid nitrogen and as part of a study of serial assays on a single tumor biopsy, alternative storage media were investigated. This study shows that storage of breast tumor biopsies at -20 degrees in sucrose buffer made 50% in glycerol prevented the tissues from freezing, yet retained the specific estrogen receptor content both quantitatively and in terms of molecular form (8S:4S ratio). Receptor was stable for up to 100 days, and individual samples could be successfully reassayed throughout this period. Forty-four biopsies from 40 patients were halved, and one section from each was stored in liquid nitrogen, while the other was stored in sucrose:glycerol. Overall, the correlation of receptor content between the two storage methods was good. Using a clinical cutoff value of 20 fmol/mg cytosol protein, only one sample of the 44 would have been classified differently after storage in the two media. Progesterone receptor in biopsies stored in sucrose:glycerol also appears to be stable for at least a limited period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722773

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein/presenilin 1 transgenic mice.

Authors:  M Popović; M Caballero-Bleda; I Kadish; T Van Groen
Journal:  Neuroscience       Date:  2008-05-24       Impact factor: 3.590

2.  Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy.

Authors:  L Castagnetta; G Carruba; M Calabrò; L Polito; L Blasi; M Pavone-Macaluso
Journal:  Urol Res       Date:  1991

3.  Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.

Authors:  S von Kleist; J Berling; J Koltzenburg; H Gropp
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 4.  The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings.

Authors:  Maryam Shabihkhani; Gregory M Lucey; Bowen Wei; Sergey Mareninov; Jerry J Lou; Harry V Vinters; Elyse J Singer; Timothy F Cloughesy; William H Yong
Journal:  Clin Biochem       Date:  2014-01-12       Impact factor: 3.281

5.  Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate.

Authors:  L Castagnetta; G Carruba; E Fecarotta; M Lo Casto; R Cusimano; M Pavone-Macaluso
Journal:  Urol Res       Date:  1992

6.  Epidermal growth factor receptor in breast cancer: storage conditions affecting measurement, and relationship to steroid receptors.

Authors:  W R McLeay; D J Horsfall; R Seshadri; D A Morrison; G T Saccone
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Steroid hormone receptors in human salivary gland tumours.

Authors:  P J Lamey; R E Leake; S K Cowan; D S Soutar; I A McGregor; F M McGregor
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

8.  Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts.

Authors:  Nina Oparina; Malin C Erlandsson; Anna Fäldt Beding; Toshima Parris; Khalil Helou; Per Karlsson; Zakaria Einbeigi; Maria I Bokarewa
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

9.  Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

Authors:  S Nicholson; J Richard; C Sainsbury; P Halcrow; P Kelly; B Angus; C Wright; J Henry; J R Farndon; A L Harris
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  Epidermal growth factor receptors (EGFR) in human ovarian cancer.

Authors:  O J Owens; C Stewart; I Brown; R E Leake
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.